GW Pharmaceuticals was a biopharmaceutical company focused on developing and commercializing cannabinoid-based prescription medicines. Its products and pipeline targeted neurological and other conditions, including rare forms of epilepsy.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!